The diversity of <i>SNCA</i> transcripts in neurons, and its impact on antisense oligonucleotide therapeuticsJames R. Evans, Sonia Gandhi, Alexander Röntgen et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 9
GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppressionDilan Athauda, Sonia Gandhi, James R. Evans et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 7
TDP-43 loss of function drives aberrant splicing in Parkinson’s diseaseJonathan Brenton, Mina Ryten, Jordan Follett et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1